Rifaximin in the Treatment of Irritable Bowel Syndrome-Reference-Cited by-同舟云学术

Rifaximin in the Treatment of Irritable Bowel Syndrome

Published:2013-03 Issue:3 Volume:47 Page:205-211
ISSN:0192-0790
Container-title:Journal of Clinical Gastroenterology
language:en
Short-container-title:

Author:

Farrell David J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference87 articles.

1. Antibiotic therapy for the irritable bowel syndrome.;Tack;N Engl J Med,2011

2. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.;Kassinen;Gastroenterology,2007

3. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.;Posserud;Gut,2007

4. Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study.;Pimentel;Dig Dis Sci,2006

5. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study.;Pimentel;Am J Gastroenterol,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro Inhibition of Growth, Biofilm Formation, and Persisters of Staphylococcus aureus by Pinaverium Bromide;ACS Omega;2023-03-06

2. Momordica charantia polysaccharides alleviate diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and barrier via NF-κB pathway;Allergologia et Immunopathologia;2022-05-01

3. Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis;Gastroenterology;2021-08

4. Evaluation of lactulose, lactose, and fructose breath testing in clinical practice: A focus on methane;JGH Open;2020-04

5. Targeting the pregnane X receptor using microbial metabolite mimicry;EMBO Molecular Medicine;2020-03-10